Gothamist

A non-profit newsroom, powered by WNYC.

Gothamist

WNYC Listen Live

Donate

 

 

News

Magic Mushrooms May Hold Cure For The Mondays


By

Christopher Robbins

Published Jan 23, 2012

Modified Jan 23, 2012


Share

FacebookTwitterRedditEmail


Never miss a story

 Email address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .


By

Christopher Robbins

Published Jan 23, 2012

Modified Jan 23, 2012


Share

FacebookTwitterRedditEmail


We rely on your support to make local news available to all

Make your contribution now and help Gothamist thrive in 2026. Donate today

Gothamist is funded by sponsors and member donations

Psychotropic drugs: what can't they do? Two different medical studies show that psilocybin, the active drug found in magic mushrooms, may assist in treating depression. In a study published in the Proceedings of the National Academy of Sciences, after 30 volunteers took intravenous doses of psilocybin, MRI readings showed that the portion of the brain most active in depression was lowered. Another study to be published in the British Journal of Psychiatry showed that the chemical intensified positive memories.

Robin Carhart-Harris, a co-author of the first study, released a statement quoted by Bloomberg in which she suggests that "used in combination with psychotherapy, psilocybin might help people recall positive life events and reverse pessimistic mindsets.” Rather than being hooked on Prozac for a lifetime, psilocybin could provide an "enduring benefit" after just a single dose.

Psilocybin's positive uses have been noted long before Timothy Leary founded the Harvard Psilocybin Project, as hallucinogenic mushrooms have been used therapeutically for hundreds of years. Naturally, the United States classifies them as a schedule I drug, meaning the have"a high potential for abuse" and "no legitimate medical purpose." Except when you're trying to make a Portlandia PR party bearable.

Tagged

depression

drugs

hallucinogens

magic mushrooms

psilocybin

war on drugs


Christopher Robbins

Twitter

Christopher Robbins is a New York City reporter covering transportation, affordable housing, local politics, and criminal justice. His work has also appeared in New York Magazine, The Village Voice and The New York Times. Chris is a graduate of Patrick Henry High School in Roanoke, Virginia, and enjoys biking to Fort Tilden in the summertime.

Read more

Gothamist is funded by sponsors and member donations


Gothamist is funded by sponsors and member donations


MORE news

NYPD arrests and charges city schools employee in murder of Brooklyn jogger

The NYPD said it has charged Sayed Mohassib with murder.

By

Kaya Laterman

Published Nov 7, 2026 at 1:39 p.m. ET

Modified Nov 7, 2026 at 2:07 p.m. ET


Work is underway to replace deteriorating Newark Bay Bridge, a major NY-NJ route

The new bridge should be ready in 2031, with minimal disruption to commuters while it's being built, officials say.

By

Michael Sol Warren

News

Work is underway to replace deteriorating Newark Bay Bridge, a major NY-NJ route

The new bridge should be ready in 2031, with minimal disruption to commuters while it's being built, officials say.

By

Michael Sol Warren


Quest Diagnostics pays $13M to settle kickback allegations involving NY Giants tickets

By

Kaya Laterman

Person found dead with stab wounds in Queens building, NYPD says

By

Giulia Heyward

Amtrak's Penn Station plan could funnel taxpayer money to new venue for James Dolan

By

Ramsey Khalifeh


Never miss a story

Catch up on the most important headlines with a roundup of essential NYC stories, delivered to your inbox daily.

Sign upEmail address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .